10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2012 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Net Sales | $ 17,621 | 21,244 | 19,484 |
| Cost of products sold | 4,610 | 5,598 | 5,277 |
| Marketing, selling and administrative | 4,220 | 4,203 | 3,686 |
| Advertising and product promotion | 797 | 957 | 977 |
| Research and development | 3,904 | 3,839 | 3,566 |
| Impairment charge for BMS-986094 intangible asset | 1,830 | ||
| Other (income)/expense | (80) | (334) | (93) |
| Total Expenses | 15,281 | 14,263 | 13,413 |
| Earnings Before Income Taxes | 2,340 | 6,981 | 6,071 |
| Provision for income taxes | (161) | 1,721 | 1,558 |
| Net Earnings | 2,501 | 5,260 | 4,513 |
| Net Earnings Attributable to Noncontrolling Interest | 541 | 1,551 | 1,411 |
| Net Earnings Attributable to BMS | 1,960 | 3,709 | 3,102 |
| Earnings per Common Share | |||
| Basic Earnings Per Common Share Attributable to BMS | 1.1700 | 2.1800 | 1.8000 |
| Diluted Earnings per Common Share Attributable to BMS | 1.1600 | 2.1600 | 1.7900 |
| Cash dividends declared per common share | 1.3700 | 1.3300 | 1.2900 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2012 | |||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| COMPREHENSIVE INCOME | |||
| Net Earnings | $ 2,501 | 5,260 | 4,513 |
| Other Comprehensive Income/(Loss), Net of Tax [Abstract] | |||
| Derivatives qualifying as cash flow hedges - Unrealized holding gains | 9 | 24 | 15 |
| Derivatives qualifying as cash flow hedges - Realized gains, After tax | (36) | 32 | (5) |
| Pension and other postretirement benefits - Actuarial losses | (311) | (830) | (88) |
| Pension and other postretirement benefits - Amortization | 90 | 81 | 67 |
| Pension and other postretirement benefits - Settlements and curtailments | 103 | 7 | 16 |
| Available for sale securities - Unrealized gains | 12 | 28 | 44 |
| Available for sale securities - Realized gains | (9) | ||
| Foreign currency translation | (7) | (27) | 37 |
| Foreign currency translation on net investment hedges | (8) | 11 | 84 |
| Total Other Comprehensive Income/(Loss) | (157) | (674) | 170 |
| Comprehensive Income | 2,344 | 4,586 | 4,683 |
| Comprehensive Income Attributable to Noncontrolling Interest | 535 | 1,558 | 1,411 |
| Comprehensive Income Attributable to BMS | 1,809 | 3,028 | 3,272 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2012 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings | $ 2,501 | 5,260 | 4,513 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Net earnings attributable to noncontrolling interest | (541) | (1,551) | (1,411) |
| Depreciation and amortization | 681 | 628 | 607 |
| Deferred income taxes | (1,230) | 415 | 422 |
| Stock-based compensation | 154 | 161 | 193 |
| Impairment charges | 2,180 | 28 | 228 |
| Proceeds from Amylin diabetes collaboration | 3,570 | ||
| Other adjustments | (35) | (147) | (32) |
| Changes in operating assets and liabilities: | |||
| Receivables | 648 | (220) | (270) |
| Inventories | (103) | (193) | 156 |
| Accounts payable | (232) | 593 | 315 |
| Other deferred income | 295 | 58 | 254 |
| U.S. and foreign income taxes payable | (50) | (134) | (236) |
| Other | (897) | (58) | (248) |
| Net Cash Provided by Operating Activities | 6,941 | 4,840 | 4,491 |
| Cash Flows From Investing Activities: | |||
| Proceeds from sale and maturities of marketable securities | 4,890 | 5,960 | 3,197 |
| Purchases of marketable securities | (3,607) | (6,819) | (5,823) |
| Additions to property, plant and equipment and capitalized software | (548) | (367) | (424) |
| Proceeds from sale of businesses and other investing activities | 68 | 149 | 67 |
| Purchases of businesses, net of cash acquired | (7,530) | (360) | (829) |
| Net Cash Used in Investing Activities | (6,727) | (1,437) | (3,812) |
| Cash Flows From Financing Activities: | |||
| Short-term debt borrowings/(repayments) | 49 | (1) | (33) |
| Proceeds from issuance of long-term debt | 1,950 | 6 | |
| Long-term debt repayments | (2,108) | (78) | (936) |
| Interest rate swap terminations | 2 | 296 | 146 |
| Issuances of common stock | 463 | 601 | 252 |
| Common stock repurchases | (2,403) | (1,221) | (576) |
| Dividends paid | (2,286) | (2,254) | (2,202) |
| Net Cash Used in Financing Activities | (4,333) | (2,657) | (3,343) |
| Effect of Exchange Rates on Cash and Cash Equivalents | (1) | (3) | 14 |
| (Decrease)/Increase in Cash and Cash Equivalents | (4,120) | 743 | (2,650) |
| Cash and Cash Equivalents at Beginning of Period | 5,776 | 5,033 | |
| Cash and Cash Equivalents at End of Period | 1,656 | 5,776 | 5,033 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2012 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2012 | Dec 31, 2011 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 1,656 | 5,776 |
| Marketable securities | 1,173 | 2,957 |
| Receivables | 3,083 | 3,743 |
| Inventories | 1,657 | 1,384 |
| Deferred income taxes | 1,597 | 1,200 |
| Prepaid expenses and other | 355 | 258 |
| Total Current Assets | 9,521 | 15,318 |
| Property, plant and equipment | 5,333 | 4,521 |
| Goodwill | 7,635 | 5,586 |
| Other intangible assets | 8,778 | 3,124 |
| Deferred income taxes | 203 | 688 |
| Marketable securities | 3,523 | 2,909 |
| Other assets | 904 | 824 |
| Total Assets | 35,897 | 32,970 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short term borrowings and current portion of long-term debt | 115 | |
| Short-term borrowings and current portion of long-term debt | 826 | |
| Accounts payable | 2,202 | 2,603 |
| Accrued expenses | 2,573 | 2,791 |
| Deferred income | 825 | 337 |
| Accrued rebates and returns | 1,054 | 1,170 |
| U.S. and foreign income taxes payable | 193 | 167 |
| Dividends payable | 606 | 597 |
| Total Current Liabilities | 8,279 | 7,780 |
| Pension, postretirement, and postemployment liabilities | 1,882 | 2,017 |
| Deferred income | 4,024 | 866 |
| U.S. and foreign income taxes payable | 648 | 573 |
| Deferred income taxes | 383 | 107 |
| Other liabilities | 475 | 384 |
| Long-term debt | 6,568 | 5,376 |
| Total Liabilities | 22,259 | 17,103 |
| Commitments and contingencies (Note 21) | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,117 in 2012 and 5,268 in 2011, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2012 and 2011 | 221 | 220 |
| Capital in excess of par value of stock | 2,694 | 3,114 |
| Accumulated other comprehensive loss | (3,202) | (3,045) |
| Retained earnings | 32,733 | 33,069 |
| Less cost of treasury stock - 570 million common shares in 2012 and 515 million in 2011 | (18,823) | (17,402) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 13,623 | 15,956 |
| Noncontrolling interest | 15 | (89) |
| Total Equity | 13,638 | 15,867 |
| Total Liabilities and Equity | 35,897 | 32,970 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |